Yin Cunlin, Zhang Yaming, Huang Lei. Drug Use Evaluation of Meropenem Used in Pediatrics Based on Weighted TOPSIS Metho[J]. 2023,29(3):13-17. DOI: 10.13407/j.cnki.jpp.1672-108X.2023.03.004.
Ci <0. 6 的不合理病例32 例(24. 62%)。结论:采用加权TOPSIS 法评估儿科美 罗培南的合理应用是切实可行的
我院美罗培南的应用仍存在问题
应加强管理
促进美罗培南在儿科患者中的合理应用。
Abstract
Objective: To discuss the evaluation system of pediatric meropenem to provide reference for its rational use in pediatrics. Methods: The standards of pediatric meropenem drug use evaluation (DUE) were constructed
and the weighted TOPSIS method was used to evaluate pediatric patients who used meropenem in the pediatrics department of our hospital from October 2020 to March 2021. Results: A total of 130 eligible cases were collected. According to their relative closeness to the optimal solution
38 cases (29. 23%) were reasonable with Ci ≥ 0. 8
60 cases (46. 15%) were basically reasonable with 0. 6 ≤ Ci < 0. 8
and 32 cases (24. 62%) were unreasonable with Ci < 0. 6. Conclusion: It is reasonable and feasible to use weighted TOPSIS method to evaluate meropenem in pediatrics. There are still some problems in the use of meropenem in our hospital
so we should strengthen the management and urge it to the optimal solution